Publications by authors named "R G MCLAREN"
Due to complex interactions, changes in any one area of food systems are likely to impact-and possibly depend on-changes in other areas. Here we present the first annual monitoring update of the indicator framework proposed by the Food Systems Countdown Initiative, with new qualitative analysis elucidating interactions across indicators. Since 2000, we find that 20 of 42 indicators with time series have been trending in a desirable direction, indicating modest positive change.
View Article and Find Full Text PDFObjective: In recent years, the management of placenta accreta spectrum (PAS) has fallen into two categories: planned hysterectomy and conservative management to preserve fertility. However, optimal management remains unclear. Therefore, we conducted a systematic review and meta-analysis comparing the two to evaluate which approach was associated with lower surgical morbidity.
View Article and Find Full Text PDFArticle Synopsis
- Alkuraya-Kučinskas syndrome (AKS) is a rare genetic disorder caused by mutations in the BLTP1 gene, leading to various serious developmental issues such as brain malformations, joint contractures, and clubfeet.
- A case study highlights two new mutations associated with AKS, showcasing severe anomalies in a fetus, including hydrops and brainstem kink, alongside a literature review of 19 other cases that provides insights into common prenatal features.
- The review indicates that many AKS cases present significant symptoms like joint contractures, brain issues, and facial abnormalities, stressing the importance of genetic testing for diagnosis when such features are observed in a fetus.
Propranolol to decrease time to delivery: a meta-analysis of randomized controlled trials.
Am J Obstet Gynecol MFM
October 2024
Objective: To assess the effect of propranolol on time to delivery among patients undergoing induction or augmentation of labor.
Data Sources: PubMed, Scopus, Cochrane Library, ClinicalTrials.gov, and CINAHL (EBSCO) were searched from inception to December 2023.
Background: Treatment options for severe, refractory iron deficiency anemia are limited in pregnancy.
Objective: To review the available literature on the use of recombinant erythropoietin in the treatment of iron deficiency anemia in pregnancy.
Search Strategy: An electronic search of seven databases from inception to March 2022 was performed using a combination of keywords.